A chemotherapy response prediction model derived from tumor-promoting B and Tregs and proinflammatory macrophages in HGSOC
-
Published:2023-07-14
Issue:
Volume:13
Page:
-
ISSN:2234-943X
-
Container-title:Frontiers in Oncology
-
language:
-
Short-container-title:Front. Oncol.
Author:
Xi Yue,Zhang Yingchun,Zheng Kun,Zou Jiawei,Gui Lv,Zou Xin,Chen Liang,Hao Jie,Zhang Yiming
Abstract
BackgroundMost patients with high-grade serous ovarian cancer (HGSOC) experienced disease recurrence with cumulative chemoresistance, leading to treatment failure. However, few biomarkers are currently available in clinical practice that can accurately predict chemotherapy response. The tumor immune microenvironment is critical for cancer development, and its transcriptomic profile may be associated with treatment response and differential outcomes. The aim of this study was to develop a new predictive signature for chemotherapy in patients with HGSOC.MethodsTwo HGSOC single-cell RNA sequencing datasets from patients receiving chemotherapy were reinvestigated. The subtypes of endoplasmic reticulum stress-related XBP1+ B cells, invasive metastasis-related ACTB+ Tregs, and proinflammatory-related macrophage subtypes with good predictive power and associated with chemotherapy response were identified. These results were verified in an independent HGSOC bulk RNA-seq dataset for chemotherapy. Further validation in clinical cohorts used quantitative real-time PCR (qRT-PCR).ResultsBy combining cluster-specific genes for the aforementioned cell subtypes, we constructed a chemotherapy response prediction model containing 43 signature genes that achieved an area under the receiver operator curve (AUC) of 0.97 (p = 2.1e-07) for the GSE156699 cohort (88 samples). A huge improvement was achieved compared to existing prediction models with a maximum AUC of 0.74. In addition, its predictive capability was validated in multiple independent bulk RNA-seq datasets. The qRT-PCR results demonstrate that the expression of the six genes has the highest diagnostic value, consistent with the trend observed in the analysis of public data.ConclusionsThe developed chemotherapy response prediction model can be used as a valuable clinical decision tool to guide chemotherapy in HGSOC patients.
Funder
National Natural Science Foundation of China
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference111 articles.
1. Cancer statistics, 2022;Siegel;CA: Cancer J Clin,2022
2. Staging laparotomy in early ovarian cancer;Young;Jama,1983
3. Ovarian cancer statistics, 2018;Torre;CA: Cancer J Clin,2018
4. Cancer of the ovary;Cannistra;New Engl J Med,2004
5. Ovarian cancer;Matulonis;Nat Rev Dis Primers,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献